Agilon Health Inc Stock Price, News & Analysis

agilon health, inc. (NYSE: AGL) will participate in two major investor conferences: the Wells Fargo Virtual Healthcare Conference on September 9 at 10:40 AM ET and the Morgan Stanley 19th Annual Global Healthcare Conference on September 10 at 5:00 PM ET. Both events will include fireside chat presentations, accessible through a live webcast on agilon's investor relations website. The company focuses on improving healthcare for seniors by empowering primary-care physicians with essential support and resources, fostering healthier communities and better patient care.

Agilon Health, Inc. (NYSE: AGL) reported a 70% increase in total revenue to $499 million for Q2 2021, with a year-to-date growth of 56%. Membership rose by 45% year-over-year, reaching approximately 181,700 members. However, the company faced a net loss of $299 million, a significant rise from the $8 million loss in 2020, primarily due to $275 million in stock compensation expenses. Medical Margin decreased to $55 million, and adjusted EBITDA was negative $2 million compared to a positive $14 million last year. Outlook for Q3 2021 projects revenues between $450 million and $453 million.

agilon health, inc. (NYSE: AGL) has announced it will release its financial results for Q2 2021 after market close on August 4, 2021. A conference call is scheduled for August 5, 2021, at 8:30 AM ET to discuss these results. The call can be accessed via phone or through their investor relations website. agilon health focuses on transforming healthcare for seniors, empowering primary-care physicians by providing essential support in managing their patients' overall health, which contributes to healthier communities.

agilon health (NYSE: AGL) has appointed Karen McLoughlin to its board of directors. A former CFO of Cognizant Technology Solutions, she boasts significant financial expertise, having contributed to the company's growth from $365 million to nearly $17 billion in revenue. McLoughlin's 17-year tenure at Cognizant included oversight of global finance and strategic initiatives. Board chairman Ron Williams highlighted her skills in digital transformation as critical for agilon's future. CEO Steve Sell emphasized her potential to enhance the company's platform, aligning with agilon's mission to support primary care for seniors.

agilon health, inc. (NYSE: AGL) announced its participation in two upcoming investor conferences. The company will present at the William Blair 41st Annual Growth Stock Conference on June 3 from 3:40-4:10 PM ET and at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8 from 2:10-2:50 PM ET. Interested investors can listen to live webcasts of both events on the company's investor relations page. Replays will also be available after the presentations.

Agilon Health, Inc. (NYSE: AGL) reported a strong first quarter for 2021, achieving total revenues of $413 million, a 42% increase compared to the previous year. Membership numbers grew by 35%, reaching approximately 165,300, with further increases expected due to a new group Medicare Advantage contract. Although they reported a net loss of $14 million, adjusted EBITDA improved to $4 million, up from $3 million in 2020. The company plans to support growth with IPO proceeds, aiming for 175,000 to 177,000 members by Q2 2021.

agilon health, inc. (NYSE: AGL) will release its financial results for Q1 2021 after market close on May 26, 2021. A conference call will occur on May 27, 2021, at 8:30 AM ET, to discuss the results. Participants can join by dialing (855) 435-0829 for the U.S. or +1 (639) 491-2399 internationally, using the code 9436419. The call will be available for on-demand listening shortly after. agilon health focuses on empowering primary-care physicians for better patient care, especially for seniors, aiming to transform healthcare delivery.

agilon health, inc. (NYSE: AGL) successfully closed its initial public offering of 53,590,000 shares at $23.00 each, generating approximately $1,233 million in gross proceeds. This includes the full exercise of underwriters’ option for an additional 6,990,000 shares. Trading commenced on the New York Stock Exchange on April 15, 2021. The offering was led by J.P. Morgan, Goldman Sachs & Co. LLC, and BofA Securities. agilon health empowers primary care physicians to enhance value-based healthcare delivery, focusing on senior patients.

agilon health has priced its initial public offering (IPO) at $23.00 per share, offering 46,600,000 shares for a total gross proceeds of approximately $1,072 million. The shares will start trading on the New York Stock Exchange under the ticker symbol AGL on April 15, 2021, with the expected closing date on April 19, 2021. The underwriters have a 30-day option to purchase an additional 6,990,000 shares. The offering is managed by J.P. Morgan, Goldman Sachs, and BofA Securities, among others.